Hansoh Pharmaceutical Group Company Limited : Regulator grants breakthrough-therapy status to lung cancer drug - InvestingChannel

Hansoh Pharmaceutical Group Company Limited : Regulator grants breakthrough-therapy status to lung cancer drug

Founded in 1995, HKG is a leading pharmaceutical company engaged in the research and development, manufacture and sale of pharmaceutical products in China. The company is one of the top 100 pharmaceutical companies in the world and one of the top three industrial enterprises in China in terms of pha…
© MarketScreener.com 2024

Related posts

Advisors in Focus- January 6, 2021

Gavin Maguire

Advisors in Focus- February 15, 2021

Gavin Maguire

Advisors in Focus- February 22, 2021

Gavin Maguire

Advisors in Focus- February 28, 2021

Gavin Maguire

Advisors in Focus- March 18, 2021

Gavin Maguire

Advisors in Focus- March 21, 2021

Gavin Maguire